Cosmo Pharmaceuticals N.V.

SIX:COPN.SW

65.2 (CHF) • At close November 5, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) CHF.

20232022202120202019201820172016201520142013201220112010200920082007200620052004
Assets:
Current Assets:
Cash & Cash Equivalents 50.275185.825198.56185.937110.387210.689144.944117.64971.27634.13846.33827.30213.62428.35117.16122.16625.5051.1190.6830.274
Short Term Investments 055.12823.64726.915157.822138.74727.75948.83645.06325.326121.823000.1010.13900000
Cash and Short Term Investments 50.275240.953222.207212.852268.209349.436172.703166.485116.33959.464168.16127.30213.62428.45217.322.16625.5051.1190.6830.274
Net Receivables 28.45438.61224.45126.9919.07512.76213.1914.96816.8054.79611.6196.2350000.5780000
Inventory 14.19811.49813.1195.7076.1433.9373.2412.3042.2473.3262.8592.1921.8381.2991.5151.5071.5490.9661.3061.021
Other Current Assets 9.29953.64639.71934.234166.76134.72421.36218.28519.3447.91917.31110.48613.13513.68911.0119.4426.6127.8996.3162.847
Total Current Assets 102.226306.097275.849252.868302.365374.167197.306187.074137.9370.709188.33139.9828.59743.4429.82633.69333.6669.9848.3054.142
Non-Current Assets:
Property, Plant & Equipment, Net 28.58830.27730.47829.30230.18728.61630.15220.67221.1321.44521.70422.2286.0016.4446.816.9866.8917.09612.9529.559
Goodwill 24.00524.00524.0051.4391.4391.4390.1090.1090.1090.1090.1090.1090.1090.1090.1090.1090.1090.1090.1090.109
Intangible Assets 368.993366.838372.73326.6449.21735.52428.52519.5464.49610.30516.34622.15221.96920.38712.0356.8563.1753.3840.9280.95
Goodwill and Intangible Assets 392.998390.843396.73828.07950.65636.96328.63419.6554.60510.41416.45522.26122.07820.49612.1446.9653.2843.4931.0371.059
Long Term Investments 3.286-46.85525.43223.69521.63233.51201.794164.659227.15895.5-106.3166.07018.07919.1032.1440000
Tax Assets 17.1314.6818.6368.19610.0111.72410.4562.5782.0572.2271.0011.3060.8071.0481.2461.2081.4341.1311.5240.664
Other Non-Current Assets 9.75264.5558.43154.021170.31140.70629.63248.83645.06325.326121.823020.5552.3182.3356.7691.9531.9064.3948.039
Total Non-Current Assets 451.754453.495529.713343.293282.795251.519300.668256.4300.013154.91254.673111.86549.44148.38541.63824.07213.56213.62619.90719.321
Total Assets 553.98759.592805.562596.161585.16625.686497.974443.474437.943225.621243.004151.84578.03891.82571.46457.76547.22823.6128.21223.463
Liabilities & Equity:
Current Liabilities:
Account Payables 8.78310.65611.5868.3797.7688.80611.3286.0734.2815.4664.1574.014.1385.6034.1131.2074.8674.6663.43.113
Short Term Debt 0.897171.8270.8892.9361.50.5270.6490.8491.55521.9861.7970.8921.3211.3341.3911.543.9127.6624.088
Tax Payables 2.6812.7363.5962.8060.50.4291.5462.7820.53533.3422.0035.2770.4050.2690.540.5620.1710.6380.5380.314
Deferred Revenue 9.30305.5613.4991.27202.3843.4420.87647.4282.4215.570000.5620000
Other Current Liabilities 6.73112.4633.26.9795.1656.0125.0718.35318.335.7621.1351.0025.27920.2871.8416.2240.1712.981.0850.547
Total Current Liabilities 25.714194.94621.23621.79315.70515.34519.43218.71725.04260.6569.69912.37910.30927.2117.2889.3846.57811.55812.1477.748
Non-Current Liabilities:
Long Term Debt 0.9421.771169.028165.208163.337157.6233.8274.466.5788.939.76211.041.2842.1761.6422.90304.78313.89715.254
Deferred Revenue Non-Current 0.55900.4790.3760.308-155.7893.87-1.868-3.021-4.761-6.595-8.6731.0951.0811.558-2.03602.635-3.535-8.55
Deferred Tax Liabilities Non-Current 94.53497.09799.7496.2678.8237.4994.284.332.2793.2972.9763.442.6513.6672.2471.7311.2131.160.70.497
Other Non-Current Liabilities 3.1951.992.3922.3923.254156.154-3.5522.2773.4185.217.0079.058-0.735-0.676-1.0662.5474.29-1.874.3729.394
Total Non-Current Liabilities 99.23100.858271.648174.243175.722165.4878.4259.1999.25412.67613.1514.8654.2956.2484.3815.1455.5036.70815.43416.595
Total Liabilities 124.944295.804292.884196.036191.427180.83227.85727.91634.29673.33222.84927.24414.60433.45911.66914.52912.08118.26627.58124.343
Equity:
Preferred Stock 65.32911.49218.4500000000000000000
Common Stock 4.5624.5624.5623.913.913.913.913.7493.7493.7493.7493.7493.7493.7493.4693.4693.4692.552.552.3
Retained Earnings 232.673262.243293.311265.35272.432300.016319.62372.562372.942126.984107.63535.98517.21217.1749.5170.1160.116-4.573-4.656-3.905
Accumulated Other Comprehensive Income/Loss -22.662-11.492-18.4595.81776.62973.739-26.347-23.697-21.568-19.465-17.21-14.739-9.73-8.206-6.76900000
Other Total Stockholders Equity 142.258190.122207.40335.04840.76266.095172.93462.93248.51241.008125.96699.39651.95945.34853.57839.65131.5627.3672.7370.725
Total Shareholders Equity 422.16456.927505.276400.125393.733443.76470.117415.546403.635152.276220.14124.39163.1958.06559.79543.23635.1475.3440.631-0.88
Total Equity 429.036463.788512.678400.125393.733444.854470.117415.558403.647152.289220.155124.60163.43458.36659.79543.23635.1475.3440.631-0.88
Total Liabilities & Shareholders Equity 553.98759.592805.562596.161585.16625.686497.974443.474437.943225.621243.004151.84578.03891.82571.46457.76547.22823.6128.21223.463